Estelamari Rodriguez, MD MPH

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    AstraZeneca
    Date added:
    09/08/2023
    Date updated:
    09/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Amgen
    Date added:
    09/08/2023
    Date updated:
    09/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Pfizer
    Date added:
    09/08/2023
    Date updated:
    09/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Daiichi
    Date added:
    09/08/2023
    Date updated:
    09/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Janssen
    Date added:
    09/08/2023
    Date updated:
    09/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Oncohost
    Date added:
    09/08/2023
    Date updated:
    09/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Onc live Targeted Oncology
    Date added:
    09/08/2023
    Date updated:
    09/17/2023
Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond